N-Acetyl Cysteine Attenuates the Inflammatory Response in Warm Ischemic Pig Lungs

Journal of Surgical Research

Volumn 146, Issue 2, 2008, Pages 177-183

  Geudens, Nele ^a   Wuyts, Wim A ^a   Rega, Filip R ^a   Vanaudenaerde, Bart M ^a   Neyrinck, Arne P ^a   Verleden, Geert M ^a   Lerut, Toni E ^b   Van Raemdonck, Dirk E M ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

donation after cardiac death; lung transplantation; N acetyl cysteine; pig

Indexed keywords

ACETYLCYSTEINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; LACTATE DEHYDROGENASE; LYSOMUCIL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DEATH; CELL VIABILITY; COLD ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME ACTIVITY; EX VIVO STUDY; INFLAMMATION; ISCHEMIA; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; INFLAMMATION; ISCHEMIA; LUNG; LUNG TRANSPLANTATION; ORGAN PRESERVATION; REPERFUSION INJURY; SWINE; TEMPERATURE;

EID: 41649112509     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.05.018     Document Type: Article

References (40)

1. Christie J.D., Van Raemdonck D., de Perrot M., et al. Report of the ISHLT Working Group on Primary lung graft dysfunction Part I: Introduction and methods. J Heart Lung Transplant 24 (2005) 1451
2. Egan T.M., Boychuk J.E., Rosato K., et al. Whence the lungs?. A study to assess suitability of donor lungs for transplantation. Transplantation 53 (1992) 420
3. Van Raemdonck D.E., Rega F.R., Neyrinck A.P., et al. Non-heart-beating donors. Semin Thorac Cardiovasc Surg 16 (2004) 309
4. D'Armini A.M., Roberts C.S., Griffith P.K., et al. When does the lung die?. I. Histochemical evidence of pulmonary viability after "death.". J Heart Lung Transplant 13 (1994) 741
5. Alessandrini F., D'Armini A.M., Roberts C.S., et al. When does the lung die?. II. Ultrastructural evidence of pulmonary viability after "death.". J Heart Lung Transplant 13 (1994) 748
6. Van Raemdonck D.E., Jannis N.C., De Leyn P.R., et al. Warm ischemic tolerance in collapsed pulmonary grafts is limited to one hour. Ann Surg 228 (1998) 788
7. Trulock E.P., Edwards L.B., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 (2006) 880
8. Fiser S.M., Tribble C.G., Long S.M., et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73 (2002) 1041
9. Cross C.E., Halliwell B., Borish E.T., et al. Oxygen radicals and human disease. Ann Intern Med 107 (1987) 526
10. Dinarello C.A. Pro-inflammatory cytokines. Chest 118 (2000) 503
11. Krishnadasan B., Naidu B.V., Byrne K., et al. The role of pro-inflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 125 (2003) 261
12. Henninger D.D., Panes J., Eppihimer M., et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158 (1997) 1825
13. Wesselius L.J., Smirnov I.M., O'Brien-Ladner A.R., et al. Synergism of intratracheally administered tumor necrosis factor with interleukin-1 in the induction of lung edema in rats. J Lab Clin Med 125 (1995) 618
14. Rega F.R., Wuyts W.A., Vanaudenaerde B.M., et al. Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor. J Heart Lung Transplant 24 (2005) 1369
15. Moldeus P., and Cotgreave I.A. N-acetylcysteine. Methods Enzymol 234 (1994) 482
16. Demedts M., Behr J., Buhl R., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353 (2005) 2229
17. Serrick C., Giaid A., Reis A., et al. Prolonged ischemia is associated with more pronounced rejection in the lung allograft. Ann Thorac Surg 63 (1997) 202
18. Rega F.R., Jannis N.C., Verleden G.M., et al. Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor?. J Heart Lung Transplant 22 (2003) 1226
19. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302
20. Egan T.M., Lambert Jr. C.J., Reddick R., et al. A strategy to increase the donor pool: Use of cadaver lungs for transplantation. Ann Thorac Surg 52 (1991) 1113
21. Fiser S.M., Tribble C.G., Long S.M., et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 121 (2001) 1069
22. Eppinger M.J., Jones M.L., Deeb G.M., et al. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res 58 (1995) 713
23. Eppinger M.J., Deeb G.M., Bolling S.F., et al. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 150 (1997) 1773
24. Geudens N., Vanaudenaerde B.M., Neyrinck A.P., et al. Impact of warm ischemia on different leukocytes in bronchoalveolar lavage from mouse lung: Possible new targets to condition the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 25 (2006) 839
25. Al Mehdi A.B., Zhao G., Dodia C., et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res 83 (1998) 730
26. Fisher A.B., Al Mehdi A.B., and Manevich Y. Shear stress and endothelial cell activation. Crit Care Med 30 Suppl (2002) S192
27. Fukai M., Hayashi T., Yokota R., et al. Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radic Biol Med 38 (2005) 1372
28. Chang D.M., Hsu K., Ding Y.A., et al. Interleukin-1 in ischemia-reperfusion acute lung injury. Am J Respir Crit Care Med 156 (1997) 1230
29. Khimenko P.L., Bagby G.J., Fuseler J., et al. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol 85 (1998) 2005
30. Mal H., Dehoux M., Sleiman C., et al. Early release of pro-inflammatory cytokines after lung transplantation. Chest 113 (1998) 645
31. Rega F.R., Vanaudenaerde B.M., Wuyts W.A., et al. IL-1β in bronchial lavage fluid is a noninvasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 24 (2005) 20
32. Wuyts W.A., Vanaudenaerde B.M., Dupont L.J., et al. N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells. Eur Respir J 22 (2003) 43
33. de Perrot M., Sekine Y., Fischer S., et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165 (2002) 211
34. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10 (1991) 2247
35. Olsson B., Johansson M., Gabrielsson J., et al. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 34 (1988) 77
36. Sehirli A.O., Sener G., Satiroglu H., et al. Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. J Nephrol 16 (2003) 75
37. Wuyts W.A., Vanaudenaerde B.M., Dupont L.J., et al. N-acetylcysteine inhibits interleukin-17-induced interleukin-8 production from human airway smooth muscle cells: A possible role for antioxidative treatment in chronic lung rejection?. J Heart Lung Transplant 23 (2004) 122
38. Salom M.G., Ramirez P., Carbonell L.F., et al. Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion. Transplantation 65 (1998) 1315
39. Sekhon B., Sekhon C., Khan M., et al. N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 971 (2003) 1
40. Weinbroum A.A., Kluger Y., Ben Abraham R., et al. Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: A dose-response study. Transplantation 71 (2001) 300